Methadone Market Size

  • Report ID: 3793
  • Published Date: Nov 20, 2025
  • Report Format: PDF, PPT

Methadone Market Outlook:

Methadone Market size was valued at USD 193.93 million in 2025 and is expected to reach USD 395.99 million by 2035, registering around 7.4% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of methadone is assessed at USD 206.85 million.

The growth of the market is associated with the increasing prevalence of pain after a post-surgery treatment or treatment. The demand for methadone is driven by these pain-related issues. Methadone helps in reducing the deadly pain that takes place after a therapeutic or post-surgery treatment. As per a report from the U.S. Department of Health and Human Services, in 2019, around 20% of U.S. adults suffered from chronic diseases out of which 4% of adults felt chronic pain from the disease very hard.

Additionally, the growing number of people addicted to multiple opioids such as heroin, and morphine is also a significant factor that is anticipated to drive the growth of this market in the forecast period. Methadone helps an individual get rid of the addiction or dependency on heroin, morphine, or any other prescription painkillers. As per National Survey on Drug Use and Health, indicates that around 6 million adults globally are addicted to Heroin.


Methadone Market Size

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of methadone is assessed at USD 206.85 million.

The global methadone market size was valued at more than USD 193.93 million in 2025 and is expected to register a CAGR of over 7.4%, exceeding USD 395.99 million revenue by 2035.

North America methadone market is projected to secure a 42% revenue share, spurred by the rising incidence of drug addiction and the growing reliance on methadone for managing post-operative and substance-related pain.

Key players in the market include Eli Lilly and Company, Sanofi S.A., Hikma Labs Inc., Mallinckrodt Pharmaceuticals, Siegfried Holding AG, Johnson Matthey, Gilead Sciences, Inc., BioControl Medical, Tianjin Central Pharmaceutical Industry Co., Ltd.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos